ROIV
Roivant Sciences Ltd. · Healthcare
Director Meghan Fitzgerald sold $798K of Roivant Sciences Ltd.
Sold$798,000
$39.90Price
20,000Shares
−32%Stake
What ROIV did after the filing
- The stock from Fri, Sep 11 open, $41.22
- −15.3%
- S&P 500, same days
- +0.6%
27 of 30 trading days so far, to the Oct 20 close.
Traded Tue, Sep 8. Filed Thu, Sep 10, 9:00 PM ET, after the close. Returns use the Sep 11 open and the Oct 20 close. Not investment advice.